CMG Pharmaceutical Co., Ltd. is a South Korean pharmaceutical company that develops and sells oral thin film (OTF) pharmaceuticals. Its OTF products include Tadalafil for erectile dysfunction, Entecavir for hepatitis type B, Aripiprazole for schizophrenia, and Montelukast for asthma and allergic rhinitis. The company has a strategic collaboration agreement with Handok Inc. for cancer treatment. Formerly known as Skynewpharm Co Ltd, it changed its name to CMG Pharmaceutical Co., Ltd. in April 2013; it was founded in 2001 and is headquartered in Seoul, South Korea.